학술논문
Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
Document Type
Correspondence
Author
Source
In Journal of the American Academy of Dermatology July 2022 87(1):e47-e48
Subject
Language
ISSN
0190-9622